Cargando…
Complications in Patients With Autosomal Dominant Polycystic Kidney Disease Undergoing Ureteroscopy: A Cohort Study
BACKGROUND: Ureteroscopy is a minimally invasive treatment option for upper tract stones. The distorted kidney anatomy in patients with autosomal dominant polycystic kidney disease (ADPKD) may place them at higher risk for ureteroscopic complications. OBJECTIVE: To compare the 30-day risk of uretero...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691941/ https://www.ncbi.nlm.nih.gov/pubmed/33282326 http://dx.doi.org/10.1177/2054358120972830 |
_version_ | 1783614400733642752 |
---|---|
author | Kalatharan, Vinusha Welk, Blayne Nash, Danielle M. McArthur, Eric Slater, Justin Sarma, Sisira Pei, York Garg, Amit X. |
author_facet | Kalatharan, Vinusha Welk, Blayne Nash, Danielle M. McArthur, Eric Slater, Justin Sarma, Sisira Pei, York Garg, Amit X. |
author_sort | Kalatharan, Vinusha |
collection | PubMed |
description | BACKGROUND: Ureteroscopy is a minimally invasive treatment option for upper tract stones. The distorted kidney anatomy in patients with autosomal dominant polycystic kidney disease (ADPKD) may place them at higher risk for ureteroscopic complications. OBJECTIVE: To compare the 30-day risk of ureteroscopic complications between patients with and without ADPKD. DESIGN: Retrospective cohort study. SETTING: Ontario, Canada PATIENTS: Seventy three patients with ADPKD and 81 445 patients without ADPKD who underwent ureteroscopy for upper urinary tract stones between April 1, 2002, and March 1, 2018. MEASUREMENTS: A 30-day risk of (1) hospital presentation with ureteroscopic complications (which was a composite outcome of either emergency department visit or hospital admission with acute kidney injury, urinary tract infection, or sepsis); (2) all-cause hospital presentation; (3) all-cause hospital admission; and (4) all-cause emergency department visit. METHODS: We regressed outcomes on demographic variables, health care use in the prior 1-year, various procedures and comorbidities related to the outcome in the prior 5 years, and prescribed medications filled in the past 120 days using modified Poisson regression to compare the risk ratio (RR) of each outcome between patients with and without ADPKD. RESULTS: The median (interquartile, IQR) age was 44 (38-60 years) in the ADPKD group and 53 (42-64) in the control group. About 40% were women in both groups. The risk of ureteroscopic complications was not significantly different in patients with versus without ADPKD (8.2% vs 4.3%; adjusted RR = 1.5, 95% confidence interval [CI] = 0.7-3.2). Patients with versus without ADPKD were more likely to present to hospital after their procedure (35.6% vs. 20.0%; adjusted RR = 1.6, 95% CI = 1.2-2.2), which included a statistically significant increase in the risk of presenting to the emergency department (32.9% vs. 19.0%; adjusted RR = 1.6, 95% CI = 1.1-2.2) but not hospital admissions (10.9% vs. 5.0%; adjusted RR = 1.8, 95% CI = 0.9-3.4). LIMITATIONS: The low numbers of events led to imprecision around the estimates. CONCLUSION: Patients with ADPKD have a higher risk of return to the hospital within 30 days of ureteroscopy for stone disease. TRIAL REGISTRATION: We did not register this study. |
format | Online Article Text |
id | pubmed-7691941 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-76919412020-12-04 Complications in Patients With Autosomal Dominant Polycystic Kidney Disease Undergoing Ureteroscopy: A Cohort Study Kalatharan, Vinusha Welk, Blayne Nash, Danielle M. McArthur, Eric Slater, Justin Sarma, Sisira Pei, York Garg, Amit X. Can J Kidney Health Dis Original Clinical Research Quantitative BACKGROUND: Ureteroscopy is a minimally invasive treatment option for upper tract stones. The distorted kidney anatomy in patients with autosomal dominant polycystic kidney disease (ADPKD) may place them at higher risk for ureteroscopic complications. OBJECTIVE: To compare the 30-day risk of ureteroscopic complications between patients with and without ADPKD. DESIGN: Retrospective cohort study. SETTING: Ontario, Canada PATIENTS: Seventy three patients with ADPKD and 81 445 patients without ADPKD who underwent ureteroscopy for upper urinary tract stones between April 1, 2002, and March 1, 2018. MEASUREMENTS: A 30-day risk of (1) hospital presentation with ureteroscopic complications (which was a composite outcome of either emergency department visit or hospital admission with acute kidney injury, urinary tract infection, or sepsis); (2) all-cause hospital presentation; (3) all-cause hospital admission; and (4) all-cause emergency department visit. METHODS: We regressed outcomes on demographic variables, health care use in the prior 1-year, various procedures and comorbidities related to the outcome in the prior 5 years, and prescribed medications filled in the past 120 days using modified Poisson regression to compare the risk ratio (RR) of each outcome between patients with and without ADPKD. RESULTS: The median (interquartile, IQR) age was 44 (38-60 years) in the ADPKD group and 53 (42-64) in the control group. About 40% were women in both groups. The risk of ureteroscopic complications was not significantly different in patients with versus without ADPKD (8.2% vs 4.3%; adjusted RR = 1.5, 95% confidence interval [CI] = 0.7-3.2). Patients with versus without ADPKD were more likely to present to hospital after their procedure (35.6% vs. 20.0%; adjusted RR = 1.6, 95% CI = 1.2-2.2), which included a statistically significant increase in the risk of presenting to the emergency department (32.9% vs. 19.0%; adjusted RR = 1.6, 95% CI = 1.1-2.2) but not hospital admissions (10.9% vs. 5.0%; adjusted RR = 1.8, 95% CI = 0.9-3.4). LIMITATIONS: The low numbers of events led to imprecision around the estimates. CONCLUSION: Patients with ADPKD have a higher risk of return to the hospital within 30 days of ureteroscopy for stone disease. TRIAL REGISTRATION: We did not register this study. SAGE Publications 2020-11-24 /pmc/articles/PMC7691941/ /pubmed/33282326 http://dx.doi.org/10.1177/2054358120972830 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Clinical Research Quantitative Kalatharan, Vinusha Welk, Blayne Nash, Danielle M. McArthur, Eric Slater, Justin Sarma, Sisira Pei, York Garg, Amit X. Complications in Patients With Autosomal Dominant Polycystic Kidney Disease Undergoing Ureteroscopy: A Cohort Study |
title | Complications in Patients With Autosomal Dominant Polycystic Kidney
Disease Undergoing Ureteroscopy: A Cohort Study |
title_full | Complications in Patients With Autosomal Dominant Polycystic Kidney
Disease Undergoing Ureteroscopy: A Cohort Study |
title_fullStr | Complications in Patients With Autosomal Dominant Polycystic Kidney
Disease Undergoing Ureteroscopy: A Cohort Study |
title_full_unstemmed | Complications in Patients With Autosomal Dominant Polycystic Kidney
Disease Undergoing Ureteroscopy: A Cohort Study |
title_short | Complications in Patients With Autosomal Dominant Polycystic Kidney
Disease Undergoing Ureteroscopy: A Cohort Study |
title_sort | complications in patients with autosomal dominant polycystic kidney
disease undergoing ureteroscopy: a cohort study |
topic | Original Clinical Research Quantitative |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691941/ https://www.ncbi.nlm.nih.gov/pubmed/33282326 http://dx.doi.org/10.1177/2054358120972830 |
work_keys_str_mv | AT kalatharanvinusha complicationsinpatientswithautosomaldominantpolycystickidneydiseaseundergoingureteroscopyacohortstudy AT welkblayne complicationsinpatientswithautosomaldominantpolycystickidneydiseaseundergoingureteroscopyacohortstudy AT nashdaniellem complicationsinpatientswithautosomaldominantpolycystickidneydiseaseundergoingureteroscopyacohortstudy AT mcarthureric complicationsinpatientswithautosomaldominantpolycystickidneydiseaseundergoingureteroscopyacohortstudy AT slaterjustin complicationsinpatientswithautosomaldominantpolycystickidneydiseaseundergoingureteroscopyacohortstudy AT sarmasisira complicationsinpatientswithautosomaldominantpolycystickidneydiseaseundergoingureteroscopyacohortstudy AT peiyork complicationsinpatientswithautosomaldominantpolycystickidneydiseaseundergoingureteroscopyacohortstudy AT gargamitx complicationsinpatientswithautosomaldominantpolycystickidneydiseaseundergoingureteroscopyacohortstudy |